Status:
COMPLETED
The Effect of Fish Oil in Major Depressive Disorder
Lead Sponsor:
National Science and Technology Council, Taiwan
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The whole study was divided into two major parts: (A) the 12-week, double-blind, randomized controlled, parallel omega-3 fatty acid monotherapy study in 60 patients with mild to moderate major depress...
Eligibility Criteria
Inclusion
- DSM-IV criteria for major depressive disorder.
- Age being age 18-65.
- Capacity and willingness to give written informed consent.
Exclusion
- Any major medical illnesses.
- A recent or past history of any Axis-I diagnoses besides major depressive disorder, including psychotic disorders; cognitively impaired mental disorders; impulse control disorders; substance use disorder or substance abuse (last 6 months prior to the studies); primary anxiety disorders, including post-traumatic stress disorder and panic disorder; and bipolar disorders; or Axis-II diagnoses, i.e. borderline and antisocial personality disorder.
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00816322
Start Date
January 1 2005
End Date
December 1 2014
Last Update
April 14 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University
Taichung, Taichung, Taiwan, 404